Fingolimod granted FDA Breakthrough Therapy designation for paediatric MS
Novartis today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for fingolimod for the treatment of children and adolescents 10 years of age or older with relapsing multiple sclerosis (MS)...Read more - http://www.ms-uk.org/fingolimod-granted ... diatric-ms
Fingolimod granted FDA Breakthrough Therapy designation...
Fingolimod granted FDA Breakthrough Therapy designation...
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2296 Views
-
Last post by frodo
-
- 0 Replies
- 11237 Views
-
Last post by NHE
-
- 2 Replies
- 1666 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1254 Views
-
Last post by NHE
-
- 2 Replies
- 1920 Views
-
Last post by frodo
-
- 0 Replies
- 11887 Views
-
Last post by NHE
-
- 0 Replies
- 2631 Views
-
Last post by frodo
-
- 0 Replies
- 2777 Views
-
Last post by NHE
-
- 1 Replies
- 1950 Views
-
Last post by frodo